ライフサイエンス 新着論文レビュー

First author's

個体を用いた新しいがん治療薬の創薬の基盤

2018年2月9日

園下将大1・Ross L. Cagan 1・Arvin C. Dar 2
(米国Icahn School of Medicine at Mount Sinai,1 Department of Cell, Developmental and Regenerative Biology,2 Department of Oncological Sciences)
email:園下将大
DOI: 10.7875/first.author.2018.017

A whole-animal platform to advance a clinical kinase inhibitor into new disease space.
Masahiro Sonoshita, Alex P. Scopton, Peter M. U. Ung, Matthew A. Murray, Lisa Silber, Andres Y. Maldonado, Alexander Real, Avner Schlessinger, Ross L. Cagan, Arvin C. Dar
Nature Chemical Biology, 14, 291-298 (2018)

続きを読む